These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26499992)

  • 1. Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?
    El-Sisi Ael-D; Sokar SS; Salem TA; Abu Risha SE
    Toxicol Ind Health; 2015 Nov; 31(11):1024-36. PubMed ID: 26499992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ-dependent anti-tumor and immunomodulatory actions of pioglitazone.
    El-Sisi AE; Sokar SS; Salem TA; Abu Risha SE
    J Immunotoxicol; 2015; 12(4):308-16. PubMed ID: 25425470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
    Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
    Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
    Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
    Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
    Said MM; Bosland MC
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
    Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
    Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
    Abdel-Raheem IT; Khedr NF
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
    Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
    Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
    Maeba S; Ichiyama T; Ueno Y; Makata H; Matsubara T; Furukawa S
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):670-4. PubMed ID: 15984600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats.
    Mohamed MZ; Zenhom NM
    Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106447. PubMed ID: 32173485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
    Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
    Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
    Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
    Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
    Shiota N; Shimoura K; Okunishi H
    Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
    Zhou C; Shi X; Huang H; Zhu Y; Wu Y
    Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
    Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
    Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells.
    Tsai MJ; Chang WA; Tsai PH; Wu CY; Ho YW; Yen MC; Lin YS; Kuo PL; Hsu YL
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.
    Satapathy SR; Sjölander A
    Cancer Lett; 2020 Sep; 488():50-62. PubMed ID: 32474153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.